Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FLG retains high efficacy against mutant HBV

Nov. 3, 2003

Mechanism of anti-HBV activity of HepeX-B

Oct. 31, 2003

Evidence of antiviral activity for ISIS-14803 in chronic hepatitis C

Oct. 31, 2003

Encouraging topline results from phase III trials of cilansetron

Oct. 31, 2003

Preclinical efficacy, safety and PK data discussed for IDN-6556 at AASLD meeting

Oct. 28, 2003

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Top-line results from third phase III study of Entereg for postoperative ileus

Oct. 27, 2003

Positive preliminary results announced for tolevamer in C. difficile diarrhea

Oct. 23, 2003

Beneficial effects of rifaximin in Crohn's disease

Oct. 22, 2003

Pegasys approved in Japan

Oct. 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...